SAN903-arkiv - BioStock

ThomasFeldthus_CEO_Saniona

Saniona’s CEO: “Our development pipeline is stronger than ever”

5 March, 2024

Saniona’s CEO shares 2024 business development roadmap

Saniona’s CEO shares 2024 business development roadmap

21 December, 2023

Saniona sees potential for value-creating milestones

9 March, 2023

Scandion Oncologys vd: "Our clinical study and partnering strategy are jointly progressing"

Saniona ready for phase I with SAN903

9 November, 2022

Iconovo

Saniona receives heightened interest in Q2

31 August, 2022

Saniona on the paused Tesomet programmes and restructuring

4 April, 2022

Saniona starts 2022 with three clinical trials

Saniona begins 2022 with three clinical trials ongoing

4 January, 2022

Saniona’s founder on 10 years of history and the future

11 November, 2021

Saniona’s clinical and regulatory progress during H1

31 August, 2021

Saniona’s CEO on year-end results and the company’s long-term goals

18 March, 2021